Under the new deal, terms of which were not disclosed, Aesica will supply clinical and commercial batches of various compounds to Mitovie and will also provide formulation development services.
Mitovie chairman Vinod Kaushal told Outsourcing-pharma.com that: “Our collaboration began when we were seeking an expert formulations company and Aesica proved to be the ideal company for our needs.”
He explained that from this early formulation work the firms’ relationship has expanded to include the development of more activities to the manufacturing of finished products.
“We anticipate that Aesica will continue to expand their portfolio of products for us. They already manufacture a number of brands for Mitovie in areas such as opthamology, neurology and magnesium deficiency.”
Aesica is the second North East, UK-based contractor to be working with Mitovie.
In September Northumberland contract manufacturing organisation (CMO) SCM Pharma launched a formulation development service after off the back of a collaboration with Mitovie.
At the time Dianne Sharp, managing director of SCM, told Outsourcing-pharma.com that: “The work we have carried out with Mitovie has provided us with an ideal grounding of what to expect when introducing, managing and progressing such projects.
This collaboration with SCM is on-going according to the Mitovie chairman.
“Mitovie’s partnership with SCM continues to thrive very healthily building on other areas of focus for ourselves. In some cases these are complimentary to the portfolio being developed and manufactured by Aesica on behalf of Mitovie pharma.”